Enhanced Omnipod 5 Algorithm, Improved Outcomes, and What’s Next: Insulet’s ADA 2026 Highlights
Hosted by Nancy Hanna
What happens when cutting-edge innovation meets real-world results? At ADA 2026, the future of diabetes management came into sharper focus—and in this episode, we’re breaking it all down for you.
Join host Nancy Hanna alongside Medical Affairs experts Kellee Miller and Jennifer Boyd as they unpack the most exciting Insulet data emerging from this year’s Scientific Sessions in New Orleans. From the latest Omnipod® 5 enhancements—including a new lower glucose target and expanded sensor compatibilities —to early real-world insights showing meaningful gains in time in range1, the conversation is packed with breakthroughs that matter.
You’ll also get an inside look at the real-world glycemic outcomes using Omnipod Discover™, a powerful new data platform designed to enhance engagement with diabetes data2; the STRIVE trial exploring the next-generation Omnipod® 6 system*; and a vision for a fully closed-loop system for type 2 diabetes*, designed to reduce burden, simplify care, and expand access.
Whether you’re a clinician, researcher, or passionate about advancing diabetes care, this is your front-row seat to the innovations shaping what’s next.
Time stamps:
1:10 – Omnipod 5 is now even stronger, with a lower Target Glucose of 100 mg/dL & more time in Automated Mode
3:16 – Discover™: Designed to streamline care and deliver meaningful insights
5:32 – STRIVE*: Omnipod 6 pivotal trial shows strong glycemic outcomes with fewer boluses3
8:44 – EVOLUTION 3*: Pre-pivotal study for Fully Closed Loop (FCL)* for type 2 diabetes4
How do medical devices like Omnipod 5 improve the lives of people living with diabetes? How can Healthcare Professionals implement Omnipod 5 Automated Insulin Delivery (AID) Systems in practice?
Beyond the Bolus is a US-based diabetes education podcast for healthcare professionals who treat patients living with type 1 (t1d) and type 2 diabetes (t2d).
Hosted by Insulet’s Clincial Services Mangers, Nancy Hanna RN, BSN, CDE, and Dena Gottesman MS, RD, CDCES, this dynamic duo care deeply about helping healthcare professionals (HCP)’s and patients simplify life with diabetes. Episodes cover a range of topics such as, how to get started with Omnipod 5 to ongoing care management, helping HCPs make patient conversations more efficient and effective.
Beyond the Bolus also dives into the latest clinical research and data with prominent diabetes experts from across the globe who share real-world experiences and offer insights into what the future of diabetes care could look like with devices like Omnipod 5.
If you’re looking to empower your patients to take back control of their diabetes, then this is the podcast for you.
1. Insulet data on file. 2026. Presented at ADA 2026 June 5-8, New Orleans LA RF-052026-00056
2. Insulet data on file. Pablo, M et al. Real-World Glycemic Outcomes Using the Omnipod Discover Data Management System.
RF-062026-00008
3. Insulet data on file. 2026. Presented at ADA 2026 June 5-8, New Orleans LA RF-052026-00027
4. Insulet data on file. 2026. Presented at ADA 2026 June 5-8, New Orleans LA RF-062026-00015
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 Automated Insulin Delivery System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Kirsty®, and Admelog®. Warning: SmartAdjust™ technology should NOT be used by anyone under the age of 2 years old. SmartAdjust™ technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population Refer to the Omnipod® 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.